Back to Directory
MediNect Ophtho
Belfast
Founded 2022
Specialist preclinical CRO for ophthalmic retinal disease drug development
MediNect Ophtho is a contract research organisation providing specialist preclinical services for ophthalmic drug development, with an exclusive focus on retinal disease.
Operating from Belfast, the company offers in vivo and ex vivo retinal disease models, proof-of-concept studies, DMPK and ADME studies, and mechanism of action research for therapeutic programmes targeting conditions including diabetic retinopathy, age-related macular degeneration, and geographic atrophy.